Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation
暂无分享，去创建一个
H. Putter | M. Schilham | J. Dongen | R. Egeler | A. Lankester | J. Wijnen | V. Velden | R. M. Egeler | J. Vossen | J. V. Dongen | E. V. Wering | M. Bierings | B. Versluys | E. Wering | V. V. D. Velden | M. Schilham | J. Vossen | A. Wijkhuijs | T. Révész | R. D. Weger | J. Wijnen | M. Tol | A. Lankester | M. Bierings | RA de Weger | J J M van Dongen | J. Vossen | R A de Weger | M. van Tol | V. H. J. van der Velden | A. Lankester | E R van Wering | R. M. Egeler | M. Bierings